Vivos Therapeutics, Inc. (VVOS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $25.15M | +64.6% |
| 2024 | $15.28M | +42.4% |
| 2023 | $10.73M | -21.8% |
| 2022 | $13.72M | -59.3% |
| 2021 | $33.69M | +33.0% |
| 2020 | $25.33M | +235.4% |
| 2019 | $7.55M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $25.15M | +64.6% |
| 2024 | $15.28M | +42.4% |
| 2023 | $10.73M | -21.8% |
| 2022 | $13.72M | -59.3% |
| 2021 | $33.69M | +33.0% |
| 2020 | $25.33M | +235.4% |
| 2019 | $7.55M | — |